Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Tran

Showing results (101-110 of 170) with videos related to

Pageof 17
Sort By:
JMIR Cancer|October 28, 2022
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods StudyCiara Conduit, Christina Guo, Allan B Smith, et al.
Frontiers in Immunology|November 9, 2023
Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapyHweixian Leong Penny, Kelly Hainline, Nathaniel Theoharis, et al.
Contemporary Clinical Trials Communications|January 25, 2021
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocolDavid Pryor, Mathias Bressel, Nathan Lawrentschuk, et al.
Internal Medicine Journal|September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapyAmirrtha Srikanthan, Ben Tran, Michel Beausoleil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
Therapy-Related Myeloid Neoplasms After [<sup>177</sup>Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case SeriesMichal Eifer, Duncan E K Sutherland, Isaac Goncalves, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 6, 2023
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territoriesJa Hyeon Ku, Lui Shiong Lee, Tzu-Ping Lin, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 5, 2023
Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-PacificEiji Kikuchi, Chi-Fai Ng, Hiroshi Kitamura, et al.
Clinical Genitourinary Cancer|May 4, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry studyColin Williams, Andrisha-Jade Inderjeeth, Wei Hong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 TherapyRaghava Kashyap, James P Buteau, Nathan Papa, et al.
Pageof 17

Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
JMIR Cancer|October 28, 2022
Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods StudyCiara Conduit, Christina Guo, Allan B Smith, et al.
Frontiers in Immunology|November 9, 2023
Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapyHweixian Leong Penny, Kelly Hainline, Nathaniel Theoharis, et al.
Contemporary Clinical Trials Communications|January 25, 2021
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocolDavid Pryor, Mathias Bressel, Nathan Lawrentschuk, et al.
Internal Medicine Journal|September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Christine Semira, Hui-Li Wong, Kathryn Field, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapyAmirrtha Srikanthan, Ben Tran, Michel Beausoleil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 20, 2025
Therapy-Related Myeloid Neoplasms After [<sup>177</sup>Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case SeriesMichal Eifer, Duncan E K Sutherland, Isaac Goncalves, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 6, 2023
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territoriesJa Hyeon Ku, Lui Shiong Lee, Tzu-Ping Lin, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 5, 2023
Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-PacificEiji Kikuchi, Chi-Fai Ng, Hiroshi Kitamura, et al.
Clinical Genitourinary Cancer|May 4, 2025
Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry studyColin Williams, Andrisha-Jade Inderjeeth, Wei Hong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 25, 2026
Prognostic Value of Restaging [<sup>18</sup>F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 TherapyRaghava Kashyap, James P Buteau, Nathan Papa, et al.
Pageof 17